114 related articles for article (PubMed ID: 10415516)
21. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic inhibitory and stimulatory regulation of the L-type Ca2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase.
Belevych AE; Harvey RD
J Physiol; 2000 Oct; 528 Pt 2(Pt 2):279-89. PubMed ID: 11034618
[TBL] [Abstract][Full Text] [Related]
23. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization.
Liu J; García-Cardeña G; Sessa WC
Biochemistry; 1996 Oct; 35(41):13277-81. PubMed ID: 8873592
[TBL] [Abstract][Full Text] [Related]
24. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae.
Chambliss KL; Shaul PW
Steroids; 2002 May; 67(6):413-9. PubMed ID: 11960616
[TBL] [Abstract][Full Text] [Related]
25. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
Feron O; Michel JB; Sase K; Michel T
Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
[TBL] [Abstract][Full Text] [Related]
26. The Muscarinic Acetylcholine M
Levay MK; Throm L; Bahrami N; Wieland T
Cells; 2023 Oct; 12(20):. PubMed ID: 37887276
[TBL] [Abstract][Full Text] [Related]
27. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
28. Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase.
Ramadoss J; Pastore MB; Magness RR
Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):753-64. PubMed ID: 23745825
[TBL] [Abstract][Full Text] [Related]
29. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.
Gödecke A; Heinicke T; Kamkin A; Kiseleva I; Strasser RH; Decking UK; Stumpe T; Isenberg G; Schrader J
J Physiol; 2001 Apr; 532(Pt 1):195-204. PubMed ID: 11368026
[TBL] [Abstract][Full Text] [Related]
30. Regulation of eNOS in caveolae.
Mineo C; Shaul PW
Adv Exp Med Biol; 2012; 729():51-62. PubMed ID: 22411313
[TBL] [Abstract][Full Text] [Related]
31. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
32. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling.
Feron O; Kelly RA
Circ Res; 2001 Feb; 88(2):129-31. PubMed ID: 11157661
[No Abstract] [Full Text] [Related]
33. ERbeta has nongenomic action in caveolae.
Chambliss KL; Yuhanna IS; Anderson RG; Mendelsohn ME; Shaul PW
Mol Endocrinol; 2002 May; 16(5):938-46. PubMed ID: 11981029
[TBL] [Abstract][Full Text] [Related]
34. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
[TBL] [Abstract][Full Text] [Related]
35. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
Sowa G; Pypaert M; Sessa WC
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
[TBL] [Abstract][Full Text] [Related]
36. Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase.
Kubota I; Han X; Opel DJ; Zhao YY; Baliga R; Huang P; Fishman MC; Shannon RP; Michel T; Kelly RA
J Mol Cell Cardiol; 2000 Jul; 32(7):1239-48. PubMed ID: 10860766
[TBL] [Abstract][Full Text] [Related]
37. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
38. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis.
Shaul PW
J Physiol; 2003 Feb; 547(Pt 1):21-33. PubMed ID: 12562964
[TBL] [Abstract][Full Text] [Related]
39. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G; Dessy C; Feron O
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
[TBL] [Abstract][Full Text] [Related]
40. M(2) and M(4) muscarinic receptor subtypes couple to activation of endothelial nitric oxide synthase.
Waid DK; Chell M; El-Fakahany EE
Pharmacology; 2000 Jul; 61(1):37-42. PubMed ID: 10895079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
